Natural killer cell receptors and ligand variants modulate response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia
- Closa, L.
- Xicoy, B.
- Zamora, L.
- Estrada, N.
- Colomer, D.
- Herrero, M.J.
- Vidal, F.
- Alvarez-Larrán, A.
- Caro, J.L.
ISSN: 2059-2310, 2059-2302
Argitalpen urtea: 2022
Alea: 99
Zenbakia: 2
Orrialdeak: 93-104
Mota: Artikulua